EE440 Cost-Effectiveness Analysis of 4% Fluorouracil for the Treatment of Actinic Keratosis in the Czech Republic

Autor: Blazkova, T, Mlcoch, T, Ornstova, E, Sevec, M, Doležal, T
Zdroj: In Value in Health December 2022 25(12) Supplement:S142-S142
Databáze: ScienceDirect